Dutch food and nutrition group Royal Numico has announced that an agreement in principle has been reached to sell its subsidiaries Biodermal and Galenco, including the related production facility in Belgium, to Omega Pharma (Belgium).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The combined sales of the two subsidiaries, which are specialised in skincare products, amounted to approximately €15m (US$15.8m) in 2002.

It is expected that the sale will be finalised by the end of March 2003.

Numico has said that these divestments are in line with the strategic review of the company as announced in November 2002, whereby the company will focus on its core activities baby food and clinical nutrition.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Just Food Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving food industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now